Correlation between osteopontin messenger RNA expression and microcalcification shown on sonography in papillary thyroid carcinoma

Journal of Ultrasound in Medicine

Volumn 30, Issue 6, 2011, Pages 765-771

  Sun, Yongmei ^a   Fang, Shibao ^a   Dong, Hai ^a   Zhao, Cheng ^a   Yang, Zongli ^a   Li, Ping ^a   Wang, Jianhong ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Gene expression; Osteopontin; Papillary carcinoma; Polymerase chain reaction; Sonography; Thyroid neoplasms

Indexed keywords

CHAINS; PATHOLOGY; POLYMERASE CHAIN REACTION; RNA; TRANSCRIPTION; TUMORS; ULTRASONIC IMAGING; ULTRASONOGRAPHY;

BIOLOGICAL BEHAVIOR; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; OSTEOPONTIN; PAPILLARY CARCINOMA; PAPILLARY THYROID CARCINOMATA; REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION; THYROID NEOPLASMS;

GENE EXPRESSION;

OSTEOPONTIN; RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CALCINOSIS; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PAPILLARY CARCINOMA; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICS; THYROID TUMOR;

ADOLESCENT; ADULT; AGED; CALCINOSIS; CARCINOMA, PAPILLARY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPONTIN; REPRODUCIBILITY OF RESULTS; RNA; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC; THYROID NEOPLASMS; ULTRASONOGRAPHY; YOUNG ADULT;

EID: 79957942584     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2011.30.6.765     Document Type: Article

References (19)

1. Senger DR, Wirth DF, Hynes RO. Transformed mammalian cells secrete specific proteins and phosphoproteins. Cell 1979; 16:885-893. (Pubitemid 9161338)
2. Oldberg A, Franzén A, Heinegård D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cellbinding sequence. Proc Natl Acad Sci USA 1986; 83:8819-8823. (Pubitemid 17223492)
3. Sharp JA, Sung V, Slavin J, Thompson EW, Henderson MA. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer. Lab Invest 1999; 79:869-877. (Pubitemid 29344499)
4. Wang CS, Lin KH, Chen SL, Chan YF, Hsueh S. Overexpression of SPARC gene in human gastric carcinoma and clinic-pathologic significance. Br J Cancer 2004; 91:1924-1930. (Pubitemid 40065522)
5. Shijubo N, Uede T, Kon S, Nagata M, Abe S. Vascular endothelial growth factors and osteopontin in tumor biology. Crit Rev Oncog 2000; 11:135-146.
6. Gilles C, Bassuk JA, Pulyaeva H, Sage EH, Foidart JM, Thompson EW. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. Cancer Res 1998; 58:5529-5536. (Pubitemid 28551141)
7. Ariztia EV, Subbarao V, Solt DB, Rademaker AW, Iyer AP, Oltvai ZN. Osteopontin contributes to hepatocyte growth factor-induced tumor growth and metastasis formation. Exp Cell Res 2003; 288:257-267. (Pubitemid 36959943)
8. Ue T, Yolozaki H, Kitadai Y, et al. Co-expression of osteopontin and CD44v9 in gastric cancer. Int J Cancer 1998; 79:127-132. (Pubitemid 28201682)
9. Coppola D, Szabo M, Boulware D, et al. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res 2004; 10:184-190. (Pubitemid 38114178)
10. Khoo ML, Asa SL, Witterick IJ, Freeman JL. Thyroid calcification and its association with thyroid carcinoma. Head Neck 2002; 24:651-655. (Pubitemid 34734360)
11. Hirota S, Ito A, Nagoshi J, et al. Expression of bone matrix protein messenger ribonucleic acids in human breast cancers: possible involvement of osteopontin in development of calcifying foci. Lab Invest 1995; 72:64- 69.
12. Bellahcène A, Castronovo V. Expression of bone matrix protein in human breast cancer: potential roles in microcalcification formation and in the genesis of bone metastases. Bull Cancer 1997; 84:17-24. (Pubitemid 27099611)
13. Tókés AM, Krausz J, Kulka J, Jäckel M, Kádár A. Role of osteopontin in the formation of microcalcifications in breast cancer [in Hungarian]. Orv Hetil 2002; 143:1841-1846.
14. Shimamoto K, Endo T, Ishigaki T, Sakuma S, Makino N. Thyroid nodules: evaluation with color Doppler ultrasonography. J Ultrasound Med 1993; 12:673-678. (Pubitemid 23326464)
15. Takano T, Hasegawa Y, Matsuzuka F, et al. Gene expression profiles in thyroid carcinomas. Br J Cancer 2000; 83:1495-1502.
16. Guarino V, Faviana P, Salvatore G, et al. Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness. J Clin Endocrinol Metab 2005; 90:5270-5278. (Pubitemid 41262285)
17. Tunio GM, Hirota S, Nomura S, Kitamura Y. Possible relation of osteopontin to development of psammoma bodies in human papillary thyroid cancer. Arch Pathol Lab Med 1998; 122:1087-1090. (Pubitemid 29009401)
18. Briese J, Cheng S, Ezzat S, et al. Osteopontin (OPN) expression in thyroid carcinoma. Anticancer Res 2010; 30:1681-1688.
19. Takashima S, Fukuda H, Nomura N, Kishimoto H, Kim T, Kobayashi T. Thyroid nodules: re-evaluation with ultrasound. J Clin Ultrasound1995; 23:179-184.